Inventor · disambiguated record
Timothy P. Reilly
Also filed as: REILLY TIMOTHY P · REILLY TIMOTHY PATRICK
7 granted patents·4 pending applications·67 citations·filing 2015–2025
86Inventor score
Top patents by PatentIndex Score
11 records- 0197US9434778B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 6, 2016·31 cites·20 claims
- 0294US10189883B2Therapeutic uses of modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 29, 2019·12 cites·20 claims
- 0394US9631004B2Modified FGF-21 polypeptides comprising an internal deletion and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 25, 2017·12 cites·17 claims
- 0490US10377806B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 13, 2019·6 cites·30 claims
- 0588US11248031B2Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 15, 2022·4 cites·22 claims
- 0680US12247058B2Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 11, 2025·0 cites·21 claims
- 0776US11572405B2Combination therapy with anti-IL-8 antibodies and anti-PD-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 7, 2023·2 cites·28 claims
- 0863US2023279096A1Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0946US2025375428A1Cbl-b inhibitors and anti-pd1/anti-pd-l1 for use in the treatment of cancerHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1045US2025161278A1Cbl-b inhibitor, compositions comprising a cbl-b inhibitor in a method of treating a disease associated with cell proliferationHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1145US2025152569A1Treatment of cell proliferation-associated conditions using a combination of a clb-b inhibitor and an additional therapeutic agentHOTSPOT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy P. Reilly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →